The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Australian military to help enforce Sydney COVID-19 lockdown as cases rise

Thu, 29th Jul 2021 03:06

* Sydney records 239 COVID-19 cases in 24 hours

* 300 military personnel to aid police

* Troops to aid enforcement of lockdown

* Sydney lockdown threatens second recession
(Adds details of Australian military personnel helping enforce
lockdown of Sydney)

By Colin Packham and Renju Jose

SYDNEY, July 29 (Reuters) - Australia's military will help
enforce a lockdown in Sydney after the city of 6 million posted
a record daily rise in COVID-19 cases on Thursday and state
authorities said the outbreak was likely to get worse.

The lockdown of Australia's biggest city has increased
pressure on Prime Minister Scott Morrison, who is now trailing
in opinion polls, and heightened concern that Australia's A$2
trillion ($1.5 trillion) economy could slide into recession.

Despite an extended lockdown in Sydney since an outbreak of
the highly infectious Delta variant, 239 new locally acquired
coronavirus cases were recorded in the city over a 24-hour
period, the biggest daily rise since the pandemic began.

"We can only assume that things are likely to get worse
before they get better given the quantity of people infectious
in the community," said Gladys Berejiklian, the premier of New
South Wales state, of which Sydney is the capital.

Berejiklian said one new death took the toll from the latest
outbreak to 13 and the national total was now 921.

With little sign that of restrictions reducing infections,
Berejiklian said new curbs would be imposed on the southwestern
and western areas of Sydney where the majority of COVID-19 cases
are being found.

Residents there will be forced to wear masks outdoors and to
stay within five km (three miles) of their homes.

With even tighter restrictions set to begin on Friday, New
South Wales Police said it had asked for 300 military personnel
to help enforce lockdown orders.

The personnel will deploy on Friday, Defence Minister Peter
Dutton said, and will begin assisting police with ensuring
compliance with restrictions next week.

LOCKDOWN EXTENDED

Berejiklian extended the Sydney lockdown by another month on
Wednesday.

New South Wales accounts for over a third of Australia's
economy. Federal Treasurer Josh Frydenberg said he expected the
national economy to shrink in the September quarter but the
ability to avoid a technical recession would depend on whether
New South Wales can avoid a longer lockdown.

"With respect to the December quarter, that does depend to a
large extent how successful New South Wales, our largest state
economy, is in getting on top of this virus," Frydenberg told
the Australian Broadcasting Corp.

Berejiklian has said restrictions need to remain as too few
people in Sydney are vaccinated amid tight supplies of the
Pfizer/BioNTech vaccine, with which Australia
had hoped to inoculate everyone under 60 years old.

All adults in Sydney have been urged to seek an AstraZeneca
vaccine. Some, citing rare blood clots, are reluctant
and would prefer to wait several months when Australia is
expected to receive additional Pfizer supplies.

($1 = 1.3561 Australian dollars)
(Reporting by Renju Jose and Colin Packham in Canberra;
additonal reporting by Xihao Jiang in Tokyo; Editing by Michael
Perry, Lincoln Feast and Timothy Heritage)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.